Tech Company Financing Transactions
Nalu Bio Funding Round
Nalu Bio secured a $12 million Series A funding round on 2/28/2023. Investors included Intrinsic Capital Partners, Axial VC and Bonaventure Equity.
Transaction Overview
Company Name
Announced On
2/28/2023
Transaction Type
Venture Equity
Amount
$12,000,000
Round
Series A
Investors
Proceeds Purpose
The company intends to use the funds to accelerate growth and scale production of cannabinoids for consumer products and therapeutics.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
38 Keyes Ave 200
San Francisco, CA 94129
USA
San Francisco, CA 94129
USA
Phone
Undisclosed
Website
Email Address
Overview
Nalu Bio is a world-class team of industry-leading experts dedicated to bringing scientific rigor to the production and discovery of the next generation of cannabinoid products.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Caitlyn Krebs
Chief Medical Officer
Alex Dorenbaum
Chief Technical Officer
Matthew Roberts
Co-Founder
Randall Ussery
Co-Founder
Phyllis Whiteley
Browse more venture capital transactions:
Prev: 2/28/2023: Temporal venture capital transaction
Next: 2/28/2023: Devyce venture capital transaction
Share this article
Where The Data Comes From
We do our best to document all VC transactions involving tech companies. VC investment data records reported here are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs